Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Evolva Holding SA Share Issue/Capital Change 2021

Sep 27, 2021

878_rns_2021-09-27_9f87f38b-ba4f-49ad-8dac-272c84770650.html

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

News Details

Ad-hoc | 27 September 2021 07:01

Evolva issued 40’000’000 shares out of authorized capital

Evolva Holding SA / Key word(s): Miscellaneous

27-Sep-2021 / 07:01 CET/CEST

Release of an ad hoc announcement pursuant to Art. 53 LR

The issuer is solely responsible for the content of this announcement.


PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Reinach, September 27, 2021 – Evolva (SIX:EVE), informs that it has issued 40’000’000 new shares out of authorized capital to cover present and future share delivery obligations under the convertible loan agreement with Nice & Green SA, dated June 26, 2020, as amended.

The listing and first day of trading of the 40’000’000 new registered shares on SIX Swiss Exchange occurs today, on 27 September 2021.

Disclaimer

This press release contains specific forward-looking statements, e.g. statements including terms like believe, assume, expect or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties readers should not place undue reliance on forward-looking statements. The company assumes no responsibility to update forward-looking statements or to adapt them to future events or developments.

About Evolva

Evolva is a Swiss biotech company focused on the research, development and commercialization of ingredients based on nature. We have leading businesses in Flavors and Fragrances, Health Ingredients and Health Protection. Evolva’s employees, half of which are women, are dedicated to make the best products that can contribute to health, wellbeing and sensory enjoyment. Find out more at evolva.com and connect with us on LinkedIn .

For Evolva multimedia content, please visit: evolva.com/multimedia-library .

Contact

Barbara Duci

Head of Investor and Corporate Relations

+41 61 485 2003

+41 79 739 2636

[email protected]


End of ad hoc announcement


Language: English
Company: Evolva Holding SA
Duggingerstrasse 23
4153 Reinach
Switzerland
Phone: +41 61 485 20 00
Internet: www.evolva.com
ISIN: CH0021218067
Valor: 2121806
Listed: SIX Swiss Exchange
EQS News ID: 1235996
End of Announcement EQS Group News Service

show this